Real-world evidence derived from data collected in routine clinical care is increasingly important for decision-makers in payer and regulatory environments.
Nordic health data has several characteristics that enable a globally unique research environment and thus can be used to create globally relevant evidence for decision makers.
We at Quantify are proud to be part of NORDSTAR – a multinational, three-party research collaboration with the aim to generate real-world evidence on severe asthma and thereby improving the everyday lives of asthma patients.
The NORDSTAR research platform encompasses data collected from Nordic countries (Denmark, Sweden, Norway, Finland) for more than 20 years, including >3 million asthma patients. A variety of outcomes relevant to patients, clinicians, and decision-makers have been investigated, including e.g., severe asthma prevalence, management, and clinical trajectories.
The NORDSTAR collaboration comprises of academic asthma researchers in the Nordic Severe Asthma Network (NSAN), pharmaceutical industry sponsors, and Nordic data experts at Quantify Research. This research platform illustrates how a multi-party, public-private partnership built around unique Nordic data and can create impactful research to meet the needs of healthcare practitioners and decision makers globally.
Want to know more about NORDSTAR?
Please get in contact with us and visit the NORDSTAR website: Here